Patient perspective, complexities, and challenges in managed care

Journal of Managed Care Pharmacy

Volumn 16, Issue 1 SUPPL. B, 2010, Pages

  Jan, Saira A ^a,b  

^a HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; OPIATE; NARCOTIC ANALGESIC AGENT;

BEHAVIOR THERAPY; CHRONIC PAIN; COMORBIDITY; EMERGENCY WARD; EMPLOYER; HEALTH CARE COST; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; MANAGED CARE; MANAGED CARE ORGANIZATION; MONITORING; OPIATE ADDICTION; PAIN; PATIENT CARE; PHARMACY; PHYSICIAN; PILL; RELAPSE; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; ATTITUDE TO HEALTH; CHRONIC DISEASE; HEALTH INSURANCE; INTEGRATED HEALTH CARE SYSTEM; MOTIVATION; PATIENT EDUCATION; RECURRENT DISEASE;

ANALGESICS, OPIOID; CHRONIC DISEASE; COMORBIDITY; DELIVERY OF HEALTH CARE, INTEGRATED; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MANAGED CARE PROGRAMS; MOTIVATION; OPIOID-RELATED DISORDERS; PAIN; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; RECURRENCE; TREATMENT OUTCOME;

EID: 77950511861     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2010.16.s1-b.22     Document Type: Review

References (22)

1. DHHS. Substance Abuse and Mental Health Services Administration. Center for Substance Abuse Treatment. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction - treatment improvement protocol TIP 40. Publication no. (SMA) 04-3939. Available at: http://www.ncbi.nlm.nih.gov/books/ bv.fcgi?rid=hstat5.section.72303. Accessed January 24, 2010.
2. Manlandro JJ. Buprenorphine for office-based treatment of patients with opioid addiction. J Am Osteopath Assoc. 2005;105(6 Suppl 3):S8-13.
3. Cross MA. Employers address opioid dependence: companies tackle problems in the workplace with new ideas and traditional programs. Manag Care. 2009;1(1):21-27.
4. Scott E, Borate U, Heitner S, et al. Pain management practices by internal medicine residents - a comparison before and after educational and institutional interventions. Am J Hosp Palliat Care. 2009;25(6):431-439
5. American Chronic Pain Association. ACPA chronic pain medications supplement 2008. Available at: http://www.theacpa.org/documents/ ACPA%20Chronic%20Pain%20Medications%20Supplement%202008.pdf. Accessed January 24, 2010.
6. Gordon DB, Dahl JL, Miaskowski C, et al. American Pain Society recommendations for improving the quality of acute and cancer pain management: American Pain Society quality of care task force. Arch Intern Med. 2005;165(14):1574-80. Available at: http://archinte.ama-assn.org/cgi/reprint/ 165/14/1574. Accessed January 20, 2010.
7. DHHS. Substance Abuse and Mental Health Services Administration. Center for Substance Abuse Treatment. Office of Applied Studies. Results from the 2007 national survey on drug use and health: national findings. NSDUH Series H-34, DHHS publication no. SMA 08-4343. September 2008. Available at: http://oas.samhsa.gov/nsduh/2k7nsduh/2k7Results.cfm#TOC. Accessed January 24, 2010.
8. Chaitowitz M, Tester W, Eiger G. Use of a comprehensive survey as a first step in addressing clinical competence of physicians-in-training in the management of pain. J Opioid Manag. 2005;1(2):98-108.
9. O'Toole TP, Strain EC, Wand G, et al. Outpatient treatment entry and health care utilization after a combined medical/substance abuse intervention for hospitalized medical patients. J Gen Intern Med. 2002;17(5):334-340
10. Parente ST, Kim SS, Finch MD, et al. Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data. Am J Manag Care. 2004;10(11):783-790
11. Trescot AM, Boswell MV, Atluri SL, et al. Opioid guidelines in the management of chronic noncancer pain. Pain Physician. 2006;9(1):1-39. Available at: http://www.painphysicianjournal.com/2006/january/2006;9;1-40.pdf. Accessed January 24, 2010.
12. Manchikanti L, Manchukonda R, Pampati V, et al. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Pain Physician. 2006;9(2): 123-129
13. Fishbain DA, Cole B, Lewis J, et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008;9(4):444-459 (Pubitemid 351722518)
14. Elkader AK, Brands B, Dunn E, et al. Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients. J Clin Psychopharmacol. 2009;29(1):77-81.
15. Mitchell TB, Dyer KR, Newcombe D, et al. Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure. J Clin Pharmacol. 2004;58(6):609-17.
16. Schreiber S, Peles E, Adelson M. Association between improvement in depression, reduced benzodiazepine (BDZ) abuse, and increased psychotropic medication use in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend. 2008;92(1-3):79-85. (Pubitemid 350213240)
17. Avants SK, Warburton LA, Margolin A. The influence of coping and depression on abstinence from illicit drug use in methadone-maintained patients. Am J Drug Alcohol Abuse. 2000;26(3):399-416. (Pubitemid 30667005)
18. Chaney EF, Roszell DK. Coping in opiate addicts maintained on methadone. In: Shiffman S and Wills TA, eds. Coping and Substance Abuse. Orlando, FL: Academic Press; 1985:267-293
19. Kaur AD, McQueen A, Jan S. Opioid drug utilization and cost outcomes associated with the use of buprenorphine-naloxone in patients with a history of prescription opioid use. J Manag Care Pharm. 2008;14(2):186-94. Available at: http://www.amcp.org/data/jmcp/JMCPMaga-March%2008-186-194.pdf. (Pubitemid 351447682)
20. Kakko J, Grônbladh L, Svanborg KD, et al. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. Am J Psychiatry. 2007;164(5):797-803. Available at: http://ajp.psychiatryonline.org/cgi/reprint/ 164/5/797. Accessed September 27, 2009.
21. Glabman M. Multiple therapies help curb opioid dependence. Manag Care. 2009;1(1):14-20. Available at: http://www.managedcaremag.com/supplements/0812- opioids-workplace/opioids-in-the-workplace.pdf. Accessed January 19, 2010.
22. Network for the Improvement of Addiction Treatment. Available at: https://www.niatx.net/content/contentpage.aspx?NID=9. Accessed January 24, 2010.